DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Phenytoin as an augmentation for SSRI failures: a small controlled study.

Author(s): Shapira B, Nemets B, Trachtenberg A, Belmaker RH

Affiliation(s): Schonbaum Depression Department, Herzog Hospital, Jerusalem, Israel.

Publication date & source: 2006-11, J Affect Disord., 96(1-2):123-6. Epub 2006 Jun 30.

Publication type: Randomized Controlled Trial; Research Support, Non-U.S. Gov't

BACKGROUND: Lithium augmentation of antidepressant effects in patients unimproved on antidepressants is well documented. We hypothesized that phenytoin, reported to have antimanic, antidepressant and prophylactic effects on affective disorder, might also augment in SSRI failures. METHODS: Twenty five patients were recruited and twenty had data sufficient for analysis between phenytoin and placebo in depression ratings. RESULTS: No effect was found. LIMITATIONS: This study was a small study. CONCLUSIONS: Lithium's ability to augment in antidepressant failures may not be shared with the anticonvulsant mood stabilizers.

Page last updated: 2007-05-03

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017